常任理事

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. Esophageal Neoplasms 66%
3. Esophagectomy 48%
4. Stomach Neoplasms 47%
5. Japan 46%
6. Neoplasms 42%
7. Methotrexate 38%
8. Safety 36%
9. Neoplasm Metastasis 35%
10. Pemphigus 33%
11. Esophageal Squamous Cell Carcinoma 33%
12. Therapeutics 32%
13. tocilizumab 28%
14. Lymph Nodes 26%
15. Sentinel Lymph Node 26%
16. Recurrence 23%
17. Survival 22%
18. Spine 22%
19. Joints 21%
20. Drug Therapy 20%
21. Liver Transplantation 20%
22. Chemoradiotherapy 19%
23. Colorectal Neoplasms 19%
24. Living Donors 18%
25. Liver 18%
26. Laparoscopy 17%
27. Antirheumatic Agents 17%
28. Thorax 17%
29. Ossification of Posterior Longitudinal Ligament 16%
30. Fluorouracil 16%
31. Cisplatin 16%
32. Transplants 16%
33. Adalimumab 15%
34. Breast Neoplasms 15%
35. Stomach 15%
36. Skin 15%
37. Desmoglein 3 15%
38. Autoantibodies 15%
39. Gastrectomy 15%
40. Spinal Cord 15%
41. Serum 15%
42. baricitinib 15%
43. Placebos 15%
44. Systemic Lupus Erythematosus 14%
45. Abatacept 14%
46. Spinal Cord Injuries 14%
47. Bone and Bones 14%
48. Lymph Node Excision 14%
49. Pancreatic Neoplasms 14%
50. Immunoglobulin G 14%
51. Infliximab 13%
52. Laminoplasty 13%
53. Incidence 13%
54. Knee 12%
55. Antibodies 12%
56. Biomarkers 12%
57. Immunoglobulin G4-Related Disease 12%
58. Scoliosis 12%
59. Adenocarcinoma 12%
60. Postoperative Complications 12%
61. Carcinoma 12%
62. Gastrointestinal Neoplasms 12%
63. Genes 11%
64. Retrospective Studies 11%
65. Spinal Cord Diseases 11%
66. Magnetic Resonance Imaging 11%
67. Rheumatology 11%
68. Neural Stem Cells 10%
69. Cohort Studies 10%
70. Osteoclasts 10%
71. Multicenter Studies 10%
72. Interleukin-6 10%
73. Prospective Studies 10%
74. Esophagus 10%
75. Hepatocellular Carcinoma 10%
76. Transplantation 10%
77. Etanercept 10%
78. Stem Cells 9%
79. Desmogleins 9%
80. Wounds and Injuries 9%
81. T-Lymphocytes 9%
82. Squamous Cell Carcinoma 9%
83. Cartilage 9%
84. peficitinib 9%
85. C-Reactive Protein 8%
86. Surgical Wound Infection 8%
87. Tomography 8%
88. Systematic Reviews 8%
89. Autoimmune Diseases 8%
90. filaggrin 8%
91. Pneumonia 8%
92. Pancreaticoduodenectomy 8%
93. Atopic Dermatitis 8%
94. Docetaxel 8%
95. Swine 8%
96. Knee Replacement Arthroplasties 8%
97. Lung 8%
98. Rectal Neoplasms 8%
99. Bullous Pemphigoid 7%